India's IT providers must become experts to handle biostatistics boom, says Alticure

By Natalie Morrison

- Last updated on GMT

Related tags: Business process outsourcing

Indian biostatistics: comment from Alticure
India’s IT sector must expand its knowledge base to fully meet the surge in demand for biostatistics says Alticure Research.

The firm’s MD and CEO Kannan Janakiraman contacted Outsourcing-Pharma.com over a recent report on Beroe’s view for the biostatistics outsourcing market in the country​.

The analysis found that more firms are working with providers – IT enabled services and business process outsourcing (ITES/BPO) firms – because it is more “cost effective”​ than working in the West.

Janakiraman however, said ITES and BPOs have so far failed to deliver the outsourcing needs in biostatistics and data management because of a lack of domain expertise and understanding of development needs.

He told us that if something does not change in the near future, many of the firms outsourcing their IT needs to those providers could run into trouble.

“We should keep in mind that Biostatistics and data managment needs cannot be met by employing Information technology and software tools only,”​ he said. “Instead it requires substantial domain knowledge in drug and device development science.”

Janakiraman told us that there is a way to fix the problems before it’s too late – by hiring team leaders with knowledge of the upstream process.

He said a smaller more expert team would be hugely more useful than having large unskilled group of workers, saying “they should come out of the ‘celebrity syndrome’ of being big and forming teams overnight.”

Working more with the sponsor as an equal partner was also on his action list.

“The current trend and future of Outsourcing of research and development programmes is based upon the accessibility of such expertise and reducing time not just on reducing cost,”​ he said.

Related news

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Related suppliers

Follow us

Products

View more

Webinars